Advanced search×

Exploring the genomes of cancer cells: progress and promise.

Michael R MR Stratton

Audio, Transactions of the IRE Profes... 331(6024):1553-8 (2011) PMID 21436442

The description and interpretation of genomic abnormalities in cancer cells have been at the heart of cancer research for more than a century. With exhaustive sequencing of cancer genomes across a wide range of human tumors well under way, we are now entering the end game of this mission. In the forthcoming decade, essentially complete catalogs of somatic mutations will be generated for tens of thousands of human cancers. Here, I provide an overview of what these efforts have revealed to date about the origin and behavioral features of cancer cells and how this genomic information is being exploited to improve diagnosis and therapy of the disease.

DOI: 10.1126/science.1204040
Version: za2963e q8zad q8zbd q8zc9 q8zd8 q8ze8 q8zf9 q8zg5

Similar articles you may find interesting…

  1. Genomics and the continuum of cancer care.
    Ultan McDermott, James R Downing, and Michael R Stratton

    N Engl J Med 364(4):340-50 (2011) PMID 21268726

    Microarray analysis, involving assay of the expression of thousands of genes, and systematic DNA sequencing have led to tools and medicines now used in the treatment of cancer. This article reviews recent progress in the genomic analysis of cancer.
  2. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia.
    Xose S XS Puente, Magda M Pinyol, ... Elías E Campo

    Nature 475(7354):101-5 (2011) PMID 21642962

    We performed whole-genome sequencing of four cases of CLL and identified 46 somatic mutations that potentially affect gene function. Further analysis of these mutations in 363 patients with CLL identified four genes that are recurrently mutated: notch 1 (NOTCH1), exportin 1 (XPO1), myeloid different...